retatrutide news today recency 3 Today, we shared new data from two Phase trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v ADA 2026: Retatrutide Revolution

Try This Tonight Add up your protein from today

And whatever you think of this one mans (OK, yes, slightly obsessive) quest to beat the reaper, he is right about the way the odds are stacked against us: all the bad stuff has great PR, while broccoli barely gets a look in

This expertise ensures safe, clinically appropriate prescribing and helps them develop personalized care plans that may include no medication, lower cost anti-obesity medication, an oral GLP-1 or an injectable GLP-1

FDA Approves Weight Management Drug for Patients Aged 12 and Older

They need to live in healthy homeostasis with more beneficial bacteria than harmful ones